Keeping Current CME podcast

JAK Inhibitors in Rheumatoid Arthritis: Overcoming Challenges and Maximizing Impact

0:00
38:19
Manda indietro di 15 secondi
Manda avanti di 15 secondi

See where Janus kinase (JAK) inhibitors fit into rheumatoid arthritis (RA) treatment to tackle obstacles and improve patient outcomes.

Credit available for this activity expires: 12/10/2026
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/[articleID]?ecd=bdc_podcast_libsyn_mscpedu

Altri episodi di "Keeping Current CME"